Boots shoppers looking to get into Korean beauty may be interested in a new launch that's gaining rave reviews. The Style Korean K-Beauty Journey Starter Kit is priced at £19 and contains nine ...
That’s been the question floating around ResMed’s (ASX:RMD) HQ for the past five years, given its obstructive sleep apnea (OSA) therapy rival’s absence from the US device market owing to a product ...
The AirTouch F30i Comfort mask for CPAP. [Image courtesy of Resmed] Resmed (NYSE: RMD) + announced today that it began the launch of its new AirTouch F30i Comfort mask in the U.S. The new continuous ...
ResMed Earnings Call Highlights Strong Growth, Expanding Margins and Shareholder Returns ResMed’s latest earnings call struck a notably upbeat tone, underscoring broad-based strength across revenue, ...
SAN DIEGO – Masks and accessories were the standout growth category for Resmed in the second quarter of its fiscal year 2026, with the company reporting a 16% increase in revenue in the United States, ...
In its Q2 2026 earnings call, ResMed Inc. reported an earnings per share (EPS) of $2.81, surpassing analysts’ forecast of $2.73 by 2.93%. The company matched revenue expectations at $1.4 billion.
Resmed RMD is set to release its second-quarter fiscal 2026 results on Jan. 29, after the closing bell. The renowned sleep health device maker posted adjusted earnings per share (EPS) of $2.55 in the ...
Boston Scientific BSX and Resmed RMD are two major players in the global medical devices market, with market capitalizations of $142.4 billion and $35.72 billion, respectively. Marlborough, MA-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results